Background: Previous studies indicated that carcinoembryonic antigen (CEA) could predict
the therapeutic objective response (OR) and overall survival (OS) of patients with cancers …

Aim: Definitive chemoradiotherapy (dCRT) is the standard treatment for locally advanced
unresectable esophageal squamous cell carcinoma (LU-ESCC). This study aimed to …

Evidence as to the value of preoperative carcinoembryonic antigen (CEA) in guiding
treatment for patients with colorectal cancer is conflicting. The aim of this prospective study …

Background: Serum tumor markers (TMs) were seldom reported in esophageal carcinoma
(ESCC), and the results were still unsatisfactory. Materials and Methods: We retrospectively …

The postoperative levels of carcinoembryonic antigen (CEA) and the actual half life (T½) of
CEA were evaluated to ascertain their potency in predicting the recurrence of colorectal …

Background We evaluated the prognostic value of the preoperative serum carcinoembryonic
antigen (CEA) level in patients with colorectal cancer (CRC). Patients and Methods The …

OBJECTIVE: To explore the clinicopathological characteristics and prognosis of colon
cancer patients with extremely elevated serum carcinoembryonic antigen (CEA) level before …

Background: To evaluate the prognostic significance of pre-and postoperative serum
carcinoembryonic antigen (CEA) levels in colorectal cancer (CRC) patients. Methods: 425 …

Introduction: We studied clinical significance based on the courses of tumor markers
following surgery for esophageal squamous cell carcinoma. Method: Tumor markers (CEA …

Background High serum carcinoembryonic antigen (CEA) levels have been reported to be
associated with poor prognosis in non-small cell lung cancer (NSCLC), while the prognostic …